Screener
Krystal Biotech, Inc. KRYS Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except per share data) | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Net income | 55,932 | 35,733 |
| Unrealized (loss) gain on available-for-sale securities | (1,577) | 344 |
| Foreign currency translation | (1,182) | 236 |
| Comprehensive income | $53,173 | $36,313 |
| Net income per common share: | ||
| Basic | $1.91 | $1.24 |
| Diluted | $1.83 | $1.20 |
| Weighted-average common shares outstanding: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Krystal Biotech, Inc. (KRYS) reported comprehensive income (loss), net of tax, attributable to parent of $53.17M in Q1 2026.
- How has Krystal Biotech, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Krystal Biotech, Inc.'s comprehensive income (loss), net of tax, attributable to parent increased by 46.4% year-over-year, from $36.31M to $53.17M.
- What is the long-term trend for Krystal Biotech, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 31.1% compound annual growth rate (CAGR), from -$69.74M to $206.16M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- Comprehensive income includes net income plus other items that bypass the income statement, such as unrealized gains or losses on investments. It provides a more holistic view of the total change in equity resulting from non-owner transactions.
Ask your AI about Krystal Biotech, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude